Comments on: Firms advise on RemeGen’s USD5.6bn AbbVie licensing deal

Comments on: Firms advise on RemeGen’s USD5.6bn AbbVie licensing deal /remegen-abbvie-licensing-deal/ Mon, 19 Jan 2026 10:48:54 +0000 hourly 1